Article
Efficacy and safety of semaglutide for obesity and hyperphagia in adults with Prader-Willi syndrome
2026-06-22
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Context</h4> Prader-Willi syndrome is a genetic neurodevelopmental disorder characterized by hyperphagia and early-onset obesity from hypothalamic dysfunction with endocrinopathies and learning disability. Management is challenging with strict control of the food environment needed. While newer glucagon-like peptide-1 receptor agonists, such as semaglutide, have efficacy in non-PWS obesity,...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0b897080-c980-553e-a63f-22b0a0d4d063
- DOI
- 10.64898/2026.06.11.26354795
